CX3CR1 and neoplasm: Our findings further demonstrated that at least 10% increase of the CX3CR1 score was predictive of response to chemo-immunotherapy with high sensitivity, specificity, PPV, and NPV, compared with pretreatment PD-L1 expression on immune and tumor cells.